Literature DB >> 23578895

Incidence and predictors of the late catch-up phenomenon after drug-eluting stent implantation.

Raisuke Iijima1, Tadashi Araki, Yoshinori Nagashima, Kenji Yamazaki, Makoto Utsunomiya, Masaki Hori, Hideki Itaya, Hideo Shinji, Masanori Shiba, Hidehiko Hara, Masato Nakamura, Kaoru Sugi.   

Abstract

BACKGROUND: Although clinical restenosis within 1 year after percutaneous coronary intervention has been remarkably reduced with the advent of drug-eluting stents (DES), the late catch-up (LCU) phenomenon remains an issue despite medical advances. The aim of this study was to investigate the incidence and predictive factors of the LCU phenomenon in an unselected population treated with first-generation DES.
METHODS: A total of 923 patients treated with DES between June 2004 and August 2008 were analyzed. The LCU phenomenon was defined as secondary revascularization 1 year after index stenting. Retreatment for very late stent thrombosis was considered as part of the LCU phenomenon.
RESULTS: Incidence of the LCU phenomenon was seen in 33 patients (3.6%). Very late stent thrombosis was observed in 5 patients (0.6%) and very late in-stent restenosis was observed in 28 patients (3.0%). At the 12-month landmark analysis, the cumulative rate of cardiac death was significantly higher in patients with the LCU phenomenon than in those without any target lesion revascularization (9.0% vs. 0.9%, p<0.001). In the multivariate analysis, hemodialysis [odds ratio (OR) 6.07, p=0.003], number of stents (OR 1.58, p=0.02), and coronary bifurcation lesions (OR 2.06, p=0.048) were identified as independent predictors of the LCU phenomenon.
CONCLUSION: The LCU phenomenon is associated with serious consequences and adverse events and remains an important issue in modern practice, despite medical advances. DES should be deployed with a minimum number of stents, and special consideration must be given to patients on hemodialysis and those with coronary bifurcation lesions.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Drug-eluting stent; Late catch-up phenomenon; Late in-stent restenosis; Percutaneous coronary intervention; Very late stent thrombosis

Mesh:

Year:  2013        PMID: 23578895     DOI: 10.1016/j.ijcard.2013.03.046

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  9 in total

1.  Initial and late efficacy of everolimus-eluting stents for small and non-small coronary lesions from evaluating delayed late loss study.

Authors:  Naoto Tama; Hiroyasu Uzui; Yuki Horita; Masanobu Namura; Hiroshi Tada
Journal:  Heart Vessels       Date:  2017-07-07       Impact factor: 2.037

2.  Tissue characteristics of neointima in late restenosis: integrated backscatter intravascular ultrasound analysis for in-stent restenosis.

Authors:  Hirohiko Ando; Akihiro Suzuki; Shinichiro Sakurai; Soichiro Kumagai; Akiyoshi Kurita; Katsuhisa Waseda; Hiroaki Takashima; Tetsuya Amano
Journal:  Heart Vessels       Date:  2016-10-11       Impact factor: 2.037

Review 3.  Pathology of Endovascular Stents.

Authors:  Kenta Nakamura; John H Keating; Elazer Reuven Edelman
Journal:  Interv Cardiol Clin       Date:  2016-05-19

4.  Late neointimal volume reduction is observed following biodegradable polymer-based drug eluting stent in porcine model.

Authors:  Takeshi Ijichi; Gaku Nakazawa; Sho Torii; Hirofumi Nagamatsu; Ayako Yoshikawa; Shintaro Nakamura; Junko Souba; Atsushi Isobe; Hitomi Hagiwara; Yuji Ikari
Journal:  Int J Cardiol Heart Vasc       Date:  2021-05-11

5.  Inverse Relationship between Serum VEGF Levels and Late In-Stent Restenosis of Drug-Eluting Stents.

Authors:  Jiasheng Yin; Li Shen; Meng Ji; Yizhe Wu; Sishi Cai; Jiahui Chen; Zhifeng Yao; Junbo Ge
Journal:  Biomed Res Int       Date:  2017-03-08       Impact factor: 3.411

6.  In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario.

Authors:  Ganesh Paramasivam; Tom Devasia; Shabeer Ubaid; Ashwitha Shetty; Krishnananda Nayak; Umesh Pai; Mugula Sudhakar Rao
Journal:  Egypt Heart J       Date:  2019-11-27

7.  Drug-eluting versus bare-metal stents for first myocardial infarction in patients with atrial fibrillation: A nationwide population-based cohort study.

Authors:  Nen-Chung Chang; Patrick Hu; Tien-Hsing Chen; Chun-Tai Mao; Ming-Jui Hung; Chi-Tai Yeh; Ming-Yow Hung
Journal:  PLoS One       Date:  2020-01-10       Impact factor: 3.240

8.  Three-year clinical outcomes of a sirolimus-eluting bioresorbable scaffold (XINSORB) and a metallic stent to treat coronary artery stenosis.

Authors:  Yizhe Wu; Zhifeng Yao; Jiasheng Yin; Jiahui Chen; Juying Qian; Li Shen; Lei Ge; Junbo Ge
Journal:  Ann Transl Med       Date:  2020-11

9.  Surface Modification of Biodegradable Polymers towards Better Biocompatibility and Lower Thrombogenicity.

Authors:  Andreas Rudolph; Michael Teske; Sabine Illner; Volker Kiefel; Katrin Sternberg; Niels Grabow; Andreas Wree; Marina Hovakimyan
Journal:  PLoS One       Date:  2015-12-07       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.